4.4 Article

Cellular rescue-assay aids verification of causative DNA-variants in mitochondrial complex I deficiency

期刊

MOLECULAR GENETICS AND METABOLISM
卷 103, 期 2, 页码 161-166

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymgme.2011.03.004

关键词

Mitochondrial disease; Complex I deficiency; NDUFS1; Lentiviral complementation; Leigh syndrome

资金

  1. Helmholtz Association
  2. German Federal Ministry of Education and Research (BMBF) [01GM0867]
  3. Systems Biology of Metabotypes (SysMBo) [0315494A]
  4. German Center for Diabetes Research
  5. Italian Ministry of Health [RF-INN-2007-634163]
  6. Jubilaumsfonds of the Oestereichische Nationalbank [12568]
  7. [HA-215]

向作者/读者索取更多资源

Mitochondria! complex I deficiency is a frequent biochemical condition, causing about one third of respiratory chain disorders. Partly due to the large number of genes necessary for its assembly and function only a small proportion of complex I deficiencies are yet confirmed at the molecular genetic level. Now, next generation sequencing approaches are applied to close the gap between biochemical definition and molecular diagnosis. Nevertheless such approaches result in a long list of novel rare single nucleotide variants. Identifying the causative mutations still remains challenging. Here we describe the identification and functional confirmation of novel NDUFS1 mutations using a cellular rescue-assay. Patient-derived complex I-defective fibroblast cell lines were transduced with wild type and mutant NDUFS1-cDNA and subsequently analyzed on the functional and protein level. We established the pathogenic nature of identified rare variants in four out of five disease alleles. This approach is a valuable add-on in disease genetics and it allows the analysis of the functional consequences of genetic variants in metabolic disorders. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study

Tim W. Rattay, Maximilian Voelker, Maren Rautenberg, Christoph Kessler, Isabel Wurster, Natalie Winter, Tobias B. Haack, Tobias Lindig, Holger Hengel, Matthis Synofzik, Rebecca Schule, Peter Martus, Ludger Schoels

Summary: This study explores early changes in the most common subtype of hereditary spastic paraplegia, SPG4, and identifies subclinical markers of disease activity in the prodromal stage. The findings suggest that certain clinical signs, such as increased reflexes and muscle weakness, may be more frequent in individuals who carry the genetic mutation associated with SPG4.
Article Genetics & Heredity

Characterization of a novel non-canonical splice site variant (c.886-5T>A) in NBAS and description of the associated phenotype

Claudia S. Priglinger, Guenter Rudolph, Irene Schmid, Pascale Mazzola, Tobias B. Haack, Milda Reith, Katarina Stingl, Nicole Weisschuh

Summary: This study presents clinical and genetic characteristics of two sisters diagnosed with optic atrophy and cone dystrophy. Genome sequencing revealed two novel variants in the NBAS gene, adding to the understanding of the genotypic and phenotypic spectrum of NBAS-related disorders.

MOLECULAR GENETICS & GENOMIC MEDICINE (2023)

Article Genetics & Heredity

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

Dmitrijs Rots, Taryn E. Jakub, Crystal Keung, Vissers E. L. M. Lisenka, Siddharth Banka, Rolph Pfundt, Bert B. A. de Vries, Richard H. van Jaarsveld, Saskia M. J. Hopman, Ellen van Binsbergen, Irene Valenzuela, Maja Hempel, Tatjana Bierhals, Fanny Kortuem, Francois Lecoquierre, Alice Goldenberg, Jens Michael Hertz, Charlotte Brasch Andersen, Maria Kibaek, Eloise J. Prijoles, Roger E. Stevenson, David B. Everman, Wesley G. Patterson, Linyan Meng, Charul Gijavanekar, Karl De Dios, Shenela Lakhani, Tess Levy, Matias Wagner, Dagmar Wieczorek, Paul J. Benke, Maria Soledad Lopez Garcia, Renee Perrier, Sergio B. Sousa, Pedro M. Almeida, Maria Jose Simoes, Bertrand Isidor, Wallid Deb, Andrew A. Schmanski, Omar Abdul-Rahman, Christophe Philippe, Ange-Line Bruel, Laurence Faivre, Antonio Vitobello, Christel Thauvin, Jeroen J. Smits, Livia Garavelli, Stefano G. Caraffi, Francesca Peluso, Laura Davis-Keppen, Dylan Platt, Erin Royer, Lisette Leeuwen, Margje Sinnema, Alexander P. A. Stegmann, Constance T. R. M. Stumpel, George E. Tiller, Danielle G. M. Bosch, Stephanus T. Potgieter, Shelagh Joss, Miranda Splitt, Simon Holden, Matina Prapa, Nicola Foulds, Sofia Douzgou, Kaija Puura, Regina Waltes, Andreas G. Chiocchetti, Christine M. Freitag, F. Kyle Satterstrom, Silvia De Rubeis, Joseph Buxbaum, Bruce D. Gelb, Aleksic Branko, Itaru Kushima, Jennifer Howe, Stephen W. Scherer, Alessia Arado, Chiara Baldo, Olivier Patat, Demeer Benedicte, Diego Lopergolo, Filippo M. Santorelli, Tobias B. Haack, Andreas Dufke, Miriam Bertrand, Ruth J. Falb, Angelika Riess, Peter Krieg, Stephanie Spranger, Maria Francesca Bedeschi, Maria Iascone, Sarah Josephi-Taylor, Tony Roscioli, Michael F. Buckley, Jan Liebelt, Aditi I. Dagli, Emmelien Aten, Anna C. E. Hurst, Alesha Hicks, Mohnish Suri, Ermal Aliu, Sunil Naik, Richard Sidlow, Juliette Coursimault, Gael Nicolas, Hanna Kuepper, Florence Petit, Veyan Ibrahim, Deniz Top, Francesca Di Cara, Raymond J. Louie, Elliot Stolerman, Han G. Brunner, Lisenka E. L. M. Vissers, Jamie M. Kramer, Tjitske Kleefstra

Summary: This study examines the clinical and molecular spectrum of individuals with KDM6B variants and challenges the accuracy of the current description of the disorder. Cognitive deficits are consistently observed, but the overall phenotype varies greatly. The study also demonstrates the disruptive effect of certain KDM6B variants on protein structure and introduces a functional testing paradigm for assessing these variants. The findings highlight the importance of international collaboration and rigorous functional analysis in diagnosing rare disorders.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

Variants in ATP5F1B are associated with dominantly inherited dystonia

Alessia Nasca, Niccolo E. Mencacci, Federica Invernizzi, Michael Zech, Ignacio J. Keller Sarmiento, Andrea Legati, Chiara Frascarelli, Bernabe Bustos, Luigi M. Romito, Dimitri Krainc, Juliane Winkelmann, Miryam Carecchio, Nardo Nardocci, Giovanna Zorzi, Holger Prokisch, Steven J. Lubbe, Barbara Garavaglia, Daniele Ghezzi

Summary: Nasca et al. have discovered a new candidate gene for dystonia, ATP5F1B, which encodes a subunit of the mitochondrial ATP synthase. This gene is associated with early-onset isolated dystonia in two families with autosomal dominant inheritance and incomplete penetrance. Functional studies showed a dominant-negative effect of the identified ATP5F1B variants, leading to reduced activity of complex V and impaired mitochondrial function.
Letter Oncology

Reply to Li and Colleagues

Christian P. Kratz, Dmitrii Smirnov, Robert Autry, Natalie Jaeger, Sebastian M. Waszak, Anika Grosshennig, Riccardo Berutti, Mareike Wendorff, Pierre Hainaut, Stefan M. Pfister, Holger Prokisch, Tim Ripperger, David Malkin

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Genetics & Heredity

Aberrant splicing prediction across human tissues

Nils Wagner, Muhammed H. Celik, Florian R. Hoelzlwimmer, Christian Mertes, Holger Prokisch, Vicente A. Yepez, Julien Gagneur

Summary: AbSplice predicts aberrant splicing in 50 human tissues by integrating deep learning models, DNA variation, and RNA-seq data. It increases prediction precision by mapping and quantifying tissue-specific splice site usage and modeling isoform competition. By incorporating RNA-sequencing data from clinically accessible tissues, precision in aberrant splicing prediction is improved to 60%.

NATURE GENETICS (2023)

Article Clinical Neurology

SLC4A10 mutation causes a neurological disorder associated with impaired GABAergic transmission

James Fasham, Antje K. Huebner, Lutz Liebmann, Reham Khalaf-Nazzal, Reza Maroofian, Nderim Kryeziu, Saskia B. Wortmann, Joseph S. Leslie, Nishanka Ubeyratna, Grazia M. S. Mancini, Marjon van Slegtenhorst, Martina Wilke, Tobias B. Haack, Hanan E. Shamseldin, Joseph G. Gleeson, Mohamed Almuhaizea, Imad Dweikat, Bassam Abu-Libdeh, Muhannad Daana, Maha S. Zaki, Matthew N. Wakeling, Lucy McGavin, Peter D. Turnpenny, Fowzan S. Alkuraya, Henry Houlden, Peter Schlattmann, Kai Kaila, Andrew H. Crosby, Emma L. Baple, Christian A. Huebner

Summary: A novel neurodevelopmental disorder associated with biallelic pathogenic variants in SLC4A10 has been identified, which exhibits learning difficulties, seizures, and characteristic brain imaging features. Dysfunction of GABAergic transmission may contribute to the disorder.
Review Endocrinology & Metabolism

Integrative omics approaches to advance rare disease diagnostics

Dmitrii Smirnov, Nikita Konstantinovskiy, Holger Prokisch

Summary: Over the past decade, high-throughput DNA sequencing approaches, such as whole exome and whole genome sequencing, have become standard procedures for diagnosing Mendelian diseases. However, the diagnostic rates vary widely and many patients remain undiagnosed. Advances in omics technologies and computational analysis offer opportunities to increase the diagnostic rates by providing evidence for disease-causing variant validation and prioritisation. This review provides an overview of the current application of various omics technologies for the diagnosis of rare genetic diseases, particularly inborn errors of metabolism.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Article Endocrinology & Metabolism

Classical homocystinuria presenting with transient basal ganglia pathology and dystonia

Luisa Averdunk, Eva Thimm, Dirk Klee, Tobias B. Haack, Felix Distelmaier

Summary: This case illustrates that classical homocystinuria is a treatable differential diagnosis of dystonia, leading to acute episodes of dystonia and brain abnormalities.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Article Clinical Neurology

Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)

Lorenzo Nanetti, Mary Kearney, Sylvia Boesch, Lucie Stovickova, Juan Dario Ortigoza-Escobar, Alfons Macaya, David Gomez-Andres, Emmanuel Roze, Maria-Judit Molnar, Nicole I. Wolf, Alejandra Darling, Gessica Vasco, Enrico Bertini, Elisabetta Indelicato, David Neubauer, Tobias B. Haack, Judit C. Sagi, Federica R. Danti, Deborah Sival, Ginevra Zanni, Anneli Kolk, Odile Boespflug-Tanguy, Ludger Schols, Bart van de Warrenburg, Marie Vidailhet, Michel A. Willemsen, Annemieke I. Buizer, Enrico Orzes, Sophie Ripp, Carola Reinhard, Isabella Moroni, Caterina Mariotti

Summary: This study investigated the transition process in the treatment network for rare neurological diseases. The findings revealed significant variations in clinical practices among different treatment centers, providing valuable data for existing transition programs and highlighting key challenges in managing transitions for patients with rare neurological disorders.

NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

ACOX1 Gain-of-Function Variant in Two German Pediatric Patients, in One Case Mimicking Autoimmune Inflammatory Disease

C. Thiels, T. Lucke, T. Rothoeft, C. Lukas, H. P. Nguyen, J. C. von Kleist-Retzow, H. Prokisch, M. Grimmel, T. B. Haack, S. Hoffjan

Summary: Mitchell syndrome is a rare genetic disorder caused by a specific de novo gain-of-function variant in ACOX1. Only five patients have been reported worldwide. We present two additional unrelated German patients with the same ACOX1 N237S variant. The clinical features include progressive hearing loss, ataxia, ichthyosis, and progressive visual impairment. Mitchell syndrome often mimics autoimmune-inflammatory diseases.

NEUROPEDIATRICS (2023)

Article Oncology

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Ralf Marienfeld, Melanie Boerries, Steffen Wolter, Markus Ball, Olaf Neumann, Sorin Armeanu-Ebinger, Christopher Schroeder, Uta Matysiak, Hannah Goldschmid, Vincent Schipperges, Axel Fuerstberger, Michael Allgaeuer, Timo Eberhardt, Jakob Niewoehner, Andreas Blaumeiser, Carolin Ploeger, Tobias Bernd Haack, Timothy Kwang Yong Tay, Olga Kelemen, Thomas Pauli, Martina Kirchner, Klaus Kluck, Alexander Ott, Marcus Renner, Jakob Admard, Axel Gschwind, Silke Lassmann, Hans Kestler, Falko Fend, Anna Lena Illert, Martin Werner, Peter Moeller, Thomas Theodor Werner Seufferlein, Nisar Malek, Peter Schirmacher, Stefan Froehling, Daniel Kazdal, Jan Budczies, Albrecht Stenzinger

Summary: With the increasing number of druggable targets and national initiatives for precision oncology, broad genomic profiling for cancer patients has become necessary. Whole exome sequencing (WES) provides unbiased analysis of coding sequences and accurate determination of complex biomarkers. Evaluating the inter-institution variability of clinical WES is important for the development of quality control frameworks.

NPJ PRECISION ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

PPA1 Deficiency Causes a Deranged Galactose Metabolism Recognizable in Neonatal Screening

Melanie T. Achleitner, Judith J. M. Jans, Laura Ebner, Johannes Spenger, Vassiliki Konstantopoulou, Rene G. Feichtinger, Karin Brugger, Doris Mayr, Ron A. Wevers, Christian Thiel, Saskia B. Wortmann, Johannes A. Mayr

Summary: Two siblings showed increased levels of galactose and related metabolites in neonatal screening, but diagnostic tests did not identify abnormalities in known disease-causing enzymes. Whole-exome sequencing revealed a homozygous missense variant in the PPA1 gene, which was found to reduce enzyme activity and protein stability. The observed metabolic derangement is hypothesized to be a mild manifestation of PPA1 deficiency.

METABOLITES (2023)

Article Endocrinology & Metabolism

Exome sequencing (ES) of a pediatric cohort with chronic endocrine diseases: a single-center study (within the framework of the TRANSLATE-NAMSE project)

Sebastian Gippert, Matias Wagner, Theresa Brunet, Riccardo Berruti, Melanie Brugger, Eva M. C. Schwaibold, Tobias B. Haack, Georg F. Hoffmann, Markus Bettendorf, Daniela Choukair

Summary: This study used exome sequencing to diagnose endocrine disorders in children and found that the overall diagnostic yield was 34.9%. The diagnostic yield varied significantly between different subgroups. The study also identified rare diseases and contributed to the identification of gene-disease associations.

ENDOCRINE (2023)

Meeting Abstract Clinical Neurology

Biallelic variants in ARHGAP19 cause mixed demyelinating and axonal polyneuropathy

S. Efthymiou, N. Dominik, X. Miao, C. Record, R. Maroofian, G. Aughrey, M. Motazacker, C. Armirola-Ricaurte, V. Lupo, T. Sevilla, N. Basak, S. Gungor, B. Aynekin, H. Per L. Van de Vondel, E. Karimiani, S. Zuchner, H. Topaloglu, A. Jordanova, R. Horvath, T. B. Haack, M. Reilly, J. Jepson, N. Lamarche-Vane, H. Houlden

EUROPEAN JOURNAL OF NEUROLOGY (2023)

暂无数据